Scientific Resources
Kymera Therapeutics to Present at Upcoming February Investor Conferences
WATERTOWN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company will present at two upcoming investor